Materials·Commodity Chemicals·$4.0B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.17 | N/A | -238.21% |
management commentary, guidance changes, and full analysis available with Pro.
| -238.21% |
Tone: Defensive
Overall, management conveyed a cautious outlook, emphasizing the need to navigate current market conditions carefully.
Management highlighted ongoing challenges in the market.
They expressed concerns about demand fluctuations.
Cabot Corp's disappointing EPS indicates significant challenges the company is facing, leading to a 5.63% drop in stock price. The lack of revenue data and guidance further adds uncertainty for investors. Management's defensive tone suggests that the company may continue to encounter difficulties in the near term.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
VERTEX PHARMACEUTICA
Oct 26, 2009